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Abstract Women with severe mental illness are at increased
risk of suicide in the perinatal period, and these suicides are
often preceded by self-harm, but little is known about self-
harm and its correlates in this population. This study aimed
to investigate the prevalence of suicidal ideation and self-
harm, and its correlates, in women with psychotic disorders
and bipolar disorder during pregnancy. Historical cohort study
using de-identified secondary mental healthcare records
linked with national maternity data. Women pregnant from
2007 to 2011, with ICD-10 diagnoses of schizophrenia and
related disorders, bipolar disorder or other affective psychoses
were identified. Data were extracted from structured fields,
natural language processing applications and free text.
Logistic regression was used to examine the correlates of
self-harm in pregnancy. Of 420 women, 103 (24.5 %) had a
record of suicidal ideation during the first index pregnancy,
with self-harm recorded in 33 (7.9 %). Self-harm was inde-
pendently associated with younger age (adjusted odds ratio
(aOR) 0.91, 95 % CI 0.85–0.98), self-harm in the previous
2 years (aOR 2.55; 1.05–6.50) and smoking (aOR 3.64; 1.30–
10.19). A higher prevalence of self-harm was observed in
women with non-affective psychosis, those who discontinued
or switched medication and in women on no medication at the
start of pregnancy, but these findings were not statistically
significant in multivariable analyses. Suicidal thoughts and
self-harm occur in a significant proportion of pregnant women
with severe mental illness, particularly younger women and
those with a history of self-harm; these women need particu-
larly close monitoring for suicidality.
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Background
The perinatal period is generally a time of both lower suicide
risk (Appleby 1991; Marzuk et al. 1997) and lower self-harm
risk (Appleby and Turnbull 1995;Weiss 1999), but for women
with severe mental disorders (SMI), the risk of suicide is in-
creased up to 70-fold in women admitted for postpartum psy-
chiatric disorders (Appleby et al. 1998). The UK Confidential
Enquiries into Maternal Deaths and other studies have
highlighted mental illness as a significant contributor to ma-
ternal deaths and also highlight a history of self-harm in a
significant proportion (25–50 %) of maternal suicides
(Kurinczuk JJ 2014). Compared with the postnatal period,
women who die by suicide during pregnancy are reported
more likely to have a diagnosis of schizophrenia/related dis-
orders or of bipolar disorder and less likely to have a diagnosis
of depression (Khalifeh et al. 2016). Little is known about the
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prevalence and risk factors of self-harm in pregnant women
with severe mental disorders even though self-harm in preg-
nancy is potentially harmful to the viability of the pregnancy
in addition to being a potential risk factor for suicide. Risk
factors for self-harm in the general population include a his-
tory of self-harm (Tidemalm et al. 2014), younger age (Moran
et al. 2012), substance misuse (Hawton et al. 2002), domestic
and sexual violence (Khalifeh et al. 2015), genetic risk
(Finseth et al. 2014) and severity of illness (Mauri et al.
2013). In addition, in pregnancy, a recent study (Zhong et al.
2015) showed younger age and depression diagnoses were
risk factors for suicidal behaviour-related hospitalisations in
pregnant women but did not look at other mental health diag-
noses. Illness severity and relapse have been associated with
discontinuation of medication in one small study in women
with bipolar disorder (Viguera et al. 2007), but associations
with risk of self-harm remain under-investigated.
We therefore aimed to investigate the prevalence of suicidal
ideation and self-harm in pregnant women with SMI (schizo-
phrenia/related disorders, bipolar disorder and other affective
psychoses). We hypothesised that self-harm would be associ-
ated with markers of illness severity (non-affective diagnosis,
substance misuse, smoking, a recent history of self-harm, re-
cent hospitalisation), younger age, discontinuation or
switching of regular maintenance psychotropic medication
and recent domestic violence.
Methods
Study design and data source
Historical cohort study uses de-identified electronic health
records. Pregnant women with SMI were identified using
the South London and Maudsley (SLaM) NIHR Biomedical
Research Centre Clinical Record Interactive Search (CRIS)
system (Stewart et al. 2009). This is a Bnew generation^ of
case register design, built on full electronic clinical records
and allowing in-depth secondary analysis of both numerical,
string and free-text data, while preserving anonymity through
technical and procedural safeguards (Fernandes et al. 2013). It
is a rich source of prospective clinical data. SLaM provides
near-monopoly mental healthcare for a geographic catchment
of around 1.2 million residents across four London boroughs,
as well as specialist services. CRIS was approved as a source
of the secondary data for research by Oxfordshire Research
Ethics Committee C (08/H0606/71+5).
Fully electronic health records have been maintained since
2006, and at the time of data extraction, over 200,000 individ-
uals had received care from SLaM. Several natural language
processing applications have been developed for CRIS using
General Architecture for Text Engineering (GATE) software
in collaboration with Sheffield University (Cunningham et al.
2013). Such applications derive structured data from free-text
fields. As part of CRIS development, a data linkage service
has been set up to link CRIS with other sources of secondary
data, including Hospital Episode Statistics (HES) which pro-
vide national statistical data for all treatment in National
Health Service hospitals in England, and includes maternity
data.
Study population
This study is part of a larger programme of research on a
cohort of pregnant women with SMI, described in detail pre-
viously (Taylor et al. 2015). The cohort includes all pregnant
women with a diagnosis of schizophrenia and other non-
affective psychoses, bipolar disorder, other affective psycho-
ses including psychotic depression or previous puerperal psy-
chosis (ICD-10 F20, F22, F23, F25, F28, F29, F30, F31,
F32.3, F33.3 and F53.1), receiving SLaM care between
2007 and 2011. We excluded women with no SLaM clinical
data during pregnancy. Structured fields and a GATE software
application were used to extract the diagnosis nearest to the
beginning of pregnancy.
Measures
We used a free-text search for records of suicidal idea-
tion (SI) and self-harm during the first index pregnancy
occurring in the study cohort. Self-harm was defined as
a suicide attempt or self-injurious behaviour, including
cutting, burning, hitting, hanging, overdosing, poisoning
and electrocuting using terms validated in another CRIS
study on self-harm and Emergency Department atten-
dances (Polling et al. 2015). Complete notes on the
self-harm event were scanned for further information
on the method of self-harm, triggers (reported hallucina-
tions around 24 h of the event, alcohol and substance
use within 12 h of the event) and location (whether
event occurred on an inpatient ward or at home and
whether the patient was under intensive Home
Treatment).
Some socio-demographic variables were extracted from
structured fields (age, ethnicity) and others from free text
(partner status in index pregnancy). Free-text searches were
also used for domestic violence before and/or during pregnan-
cy and a history of child abuse. Smoking, alcohol and sub-
stance abuse during pregnancy were extracted using free-text
searches and/or recent diagnosis of an alcohol or substance
use disorder. Measures of illness nature/severity were
affective/non-affective SMI diagnosis at the beginning of
pregnancy, self-harm and admissions to acute care in the pre-
vious 2 years. The highest total Health of the Nation Outcome
Scale (HoNOS) score in the 2 years before pregnancy was
extracted to approximate baseline level of functioning.
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HoNOS, a structured instrument, is a 12-item measure of
health and social functioning of people with severe mental
illness, routinely collected in UK mental health services;
scores above 10 indicate poor functioning and are generally
recorded in inpatients (Wing et al. 1998). Information on acute
admissions (including inpatient and intensive Home
Treatment) was extracted from CRIS and HES (Taylor et al.
2015). Home Treatment Teams are a national network of
teams providing intensive community-based support as an
alternative to hospital admission for acutely unwell patients
(Johnson et al. 2008). Regular psychotropic medication use
(antidepressants, mood stabilisers or antipsychotics) and
changes in the first trimester were also extracted: psychotropic
drug names and changes in regular use of these medication
groups during first trimester were extracted using GATE soft-
ware to guide retrieval of clinical text (Taylor et al. 2015).
Where no drugs were identified, a free-text search for
Bmedication^ was used, and where it was not possible to es-
tablish whether medication was being used or not in the first
trimester, this was coded as Bnot known.^ Regular mainte-
nance medication in the first trimester was categorised into
Bstopped or switched a medication,^ Bcontinued a
medication^ and Bno medication at the beginning of
pregnancy.^ BNon-adherence^ was coded if there was a com-
ment in the notes regarding concern about adherence indicat-
ing the possibility of no exposure to a given medication in the
first trimester. For self-harm and medication changes occur-
ring in the first trimester, we checked the notes manually to
ascertain which happened first: the self-harm or the medica-
tion change.
Data-analysis
We used Stata version 12 (Statacorp. 2011). Independent-
sample T tests and Mann-Witney tests (for continuous
data) and Pearson’s chi-square (for categorical data) were
used to compare demographic and clinical characteristics
between women with or without a record of self-harm
during pregnancy. Cells containing n< 5 were not report-
ed to maintain anonymity of the data. Cases with missing
information on presence of a partner, reported abuse,
substance misuse, current smoking and self-harm history
were assumed to indicate that these were not present.
Inter-rater agreement on self-harm data was assessed for
the first 10 records and for a 10 % random sample; two
raters agreed on 89 % of the data and consensus meet-
ings resolved discrepancies; detailed guidance on how to
code data was used for subsequent data coding.
Multivariable logistic regression analysis using cases with
known medication status was performed to examine the cor-
relates of self-harm during pregnancy. We compared these
women with those with missing medication status on age,
ethnicity, baseline diagnosis and acute admissions (variables
in the multivariable analysis that did not depend solely on
clinical text). HoNOS was not entered into the multivariable
model as data were only available for 236 of 420 women. We
conducted a sensitivity analysis excluding women who had a
self-harm event before a medication change in the first trimes-
ter in order to address the potential issue of reverse causality.
We also conducted sensitivity analyses using women who
stopped medication only compared with continuers and ex-
cluding women reported as non-adherent to medication.
Selection was based on our a priori variables and those with
p≤0.2 in the bivariate analysis. All hypothesis testing was
two-tailed with α set to 0.05.
Results
Our study population consisted of 420 women. Of these, 40
women had pregnancies which ended in the first trimester and
10 in the second. HoNOS scores were available for 236 wom-
en only, and 413 women had data on medication status in the
first index pregnancy. There was no other missing data on
covariates.
Prevalence of suicidal ideation and self-harm in the index
pregnancy, n=420 women
For 103 (24.5 %) women, there was a report of suicidal idea-
tion during the index pregnancy, while 178 (42.4 %) women
denied this; in the remaining 139 (33.1 %) women, there was
no mention of suicidal ideation or self-harm. For 70 (16.7 %)
women, there was a report of suicidal ideation but there was
no event of self-harm reported during the pregnancy. Of the
420 women in the study, 33 (7.9 %) had a self-harm event
during their index pregnancy, and 9 of these had multiple
events (range 1–7); 15 women had a self-harm event in the
first trimester, 16 in the second trimester and 10 in the third.
Self-harm by event, n=52 events
In total, 52 events of self-harm (but no suicides) were reported
in 33 women out of 420 (1 event per 19 pregnancies). Of the
52 events, methods of self-harm were overdoses (n= 20,
38.5 %), hitting (n=12, 23.1 %), cutting (n=9, 17.3 %) or
using a violent method (n=11, 21.2 %) such as jumping from
height, burning or hanging. Of 52 self-harm events, 23
(43.1 %) occurred while women experienced hallucinations.
In 18 out of 52 (34.6 %) events, drugs or alcohol were in-
volved within 12 h before the self-harm. The majority of self-
harm events took place at home (n=38, 73.1 %) compared
with an inpatient setting (n=14, 26.9 %). Of events that took
place at home (n=43), 13 (30.2 %) were carried out while the
woman was under intensive Home Treatment care.
Self-harm in pregnant women with serious mental illness
Factors associated with self-harm during the index
pregnancy, n=420 women
All women with self-harm in the first index pregnancy also
reported suicidal ideation in pregnancy. Self-harm in pregnan-
cywas associatedwith younger age, a history of child abuse or
domestic violence, current (i.e. during pregnancy) domestic
violence, a history of self-harm in the 2 years preceding preg-
nancy, substance misuse, smoking, non-affective disorder,
acute admissions in the 2 years preceding pregnancy and stop-
ping or switching rather than continuing a maintenance med-
ication in the first trimester of pregnancy (Table 1).
For multivariable analyses, 7 women were excluded as their
medication status in the first trimester of pregnancy was not
known. Therefore, 413 women were included, 33 (8.0 %) of
whom had a self-harm event in their index pregnancy. Suicidal
ideationwasnot includedintheanalysesduetoperfectprediction.
There were no differences in age (t=−0.21, p=0.833), ethnicity
(chi2=4.53,p=0.104), diagnosis (chi2=1.59,p=0.208) and ad-
mission rate (chi2=0.00, p=1.000) between those who were in-
cluded and not included in themultivariable analyses.
In the fully adjusted models (Table 2), there was
evidence of associations between self-harm in pregnancy
and younger age, smoking and a recent history of self-
harm and the adjusted odds ratio for discontinuation or
change in maintenance medication compared with con-
tinuing medication was attenuated by around 50 % and
no longer significant.
Table 1 Baseline characteristics of 420 pregnant women with SMI
Whole sample,
N= 420
387 women
without self-harm
33 women with a
self-harm event
p value
Age, mean (SD)T 31.9 (6.2) 32.3 (6.1) 27.6 (5.5) <0.001*
Ethnicity, N (%)
African Caribbean, other black background 209 (49.8) 193 (49.9) 16 (48.5) 0.283
White British, other white background 136 (32.4) 128 (33.1) 8 (24.2)
Mixed, unknown and other background 75 (17.9) 66 (17.1) 9 (27.3)
Has partner during pregnancy, N (%) 272 (64.8) 250 (64.6) 22 (66.7) 0.811
Child abuse or DV before pregnancy, N (%) 191 (45.5) 170 (43.9) 21 (63.6) 0.029*
DV in pregnancy, N (%) 82 (19.5) 70 (18.1) 12 (36.4) 0.011*
Suicidal ideation in pregnancy, N (%) 103 (24.5) 70 (18.1) 33 (100.0) >0.001*
Self-harm 2 years before pregnancy, N (%) 62 (14.8) 47 (12.1) 15 (45.5) <0.001*
Harmful use of alcohol or substances, N (%) 107 (25.5) 88 (22.7) 19 (57.6) <0.001*
Smoking in pregnancy, N (%) 76 (18.1) 58 (15.0) 18 (54.6) <0.001*
Baseline diagnosis, N (%)
Non-affective 219 (52.1) 194 (50.1) 25 (75.8) <0.005*
Affective 201 (47.9) 193 (49.9) 8 (24.2)
Hospitalisation or home treatment within 2 years before pregnancy, N (%) 180 (42.9) 158 (40.8) 22 (66.7) 0.004*
HoNOS, median (range), N = 236W 12 (0,36) 12 (0,36) 14 (3,28) 0.090
Antipsychotic or mood stabiliser, 1st trimester, N (%), n= 413 277 (67.1) 250 (65.8) 27 (81.8) 0.060
Antidepressant, 1st trimester, N (%), n = 413 99 (24.0) 91 (24.0) 8 (24.2) 0.970
Medication change, 1st trimester, N (%) n = 413
Continuation of previous agent 168 (40.7) 162 (42.6) 6 (18.2) Ref
Stopped/switched agent 117 (28.3) 101 (26.6) 16 (48.5) 0.003*
No medication at start of pregnancy 128 (31.0) 117 (30.8) 11 (33.3) 0.074
Medication change, 1st trimester sensitivity analysis, N= 409
Continued 168 (41.1) 162 (42.6) 6 (20.7) Ref
Stopped/switched 115 (28.1) 101 (26.6) 14 (48.3) 0.009*
No medication at start of pregnancy 126 (31.0) 117 (30.8) 9 (31.0) 0.177
SMI severe mental illness, DV domestic violence
*p< 0.05
T Independent-sample T tests
WMann-Whitney test
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Self-harm in pregnant women with serious mental illness
Fewer than five women had a medication change
after the self-harm event. Sensitivity analysis excluding
these women led to a further attenuation of the relation-
ship between medication changes and self-harm
(Table 2), and the association with history of self-harm
was no longer significant. Non-affective diagnosis ap-
peared to be associated with self-harm, but this did
not quite reach statistical significance (p= 0.055). Other
sensitivity analyses did not lead to substantial differ-
ences (see Table 2).
Discussion
This is the first study, to our knowledge, to report on the prev-
alence of self-harm in pregnant women with severe mental
illness, a group already recognised to be at increased risk of
maternal suicide. We found that 25 % of this cohort had record-
ed suicidal ideation in pregnancy, a similar rate to that reported
in a clinical population of 360 pregnant women referred to a
perinatal mental health programme with lifetime history of
DSM Axis I mental disorder (Newport et al. 2007). Of partic-
ular, clinical concern was our finding of self-harm in 8 %, with
violent methods used in a fifth, indicating potential severity of
intent and illness which has been found in studies of suicide in
general populations (Windfuhr and Kapur 2011) and perinatal
suicides (Khalifeh et al. 2016). We confirmed our hypotheses
that self-harm was associated with illness severity—smoking,
and previous self-harm and, though weaker evidence, non-
affective diagnosis.
Medication discontinuation was not significantly as-
sociated with self-harm, though this may reflect a lack
of statistical power. In pregnancy, clinicians as well as
patients may be concerned to avoid medication due to
concerns about teratogenicity, particularly in the first
trimester, and we have described elsewhere that
78.6 % of those who stopped medication in this cohort
were indeed recorded as stopping Bbecause of the
pregnancy^ (Taylor et al. 2015). Recent systematic re-
views and well-designed cohort studies suggest that the
small increased risk of congenital malformations in this
population appears to be due to confounding factors,
(NICE 2014; Khalifeh et al. 2015) other than for some
mood stabilisers, particularly valproate (Meador et al.
2006). While this study cannot confirm whether or not
medication changes in pregnancy could lead to self-
harm, there are likely to be complex relationships be-
tween illness severity, medication change and self-
harming behaviour that are not easy to disentangle in
observational research. Screening and close monitoring
is therefore essential for pregnant women with SMI,
particularly those with markers of severity who discontinue
medication, in order to prevent repetition of self-harm
(Moran et al. 2012).
Finally, it was noteworthy that this population had high
prevalence of substance misuse, smoking and reported domes-
tic abuse—all risk factors for adverse foetal outcomes which
need to be addressed by maternity and mental health profes-
sionals (Stein et al. 2014).
Strengths and limitations
Strengths of the study include the use of data from a
large representative sample of pregnant women with
SMI observed longitudinally within a comprehensive
clinical database. The unique features of the data source
enabled us to access data on a group who are a partic-
ularly hard-to-reach population to recruit into clinical
studies (Woodall et al. 2011). Other studies looking at
self-harm, suicide and suicidal ideation in pregnancy
have often excluded patients with SMI; utilising these
clinical records enabled us to capture a group of women
who are potentially at particular risk and yet are under-
represented in research, particularly women with schizo-
phrenia. The use of Hospital Episode Statistics provided
a robust method of identifying pregnancies regardless of
hospital of birth. It did not include home births which
account for about 2.4 % of births for England in 2011
(ONS 2013); however, as women with SMI are high-
risk pregnancies, it is unlikely that many deliver at
home. Hospital Episode Statistics also enabled us to
collect information on admission histories covering the
whole of England for this potentially mobile population.
An additional strength was the detailed information on
psychotropic medication use, in addition to histories of
abuse and other exposures usually not available in ad-
ministrative datasets.
Limitations include the use of information recorded by
clinical staff, which could underestimate suicidal ideation
and self-harm prevalence—women may not disclose suicidal
thoughts or acts as they may be worried about custody loss
(Dolman et al. 2013; Megnin-Viggars et al. 2015). There was
no mention of suicidal ideation in the notes for 33 % of wom-
en, which may have been due to suboptimal record-keeping.
Finally, we cannot assume generalisability to all women with
SMI and pregnancy as we did not include women with SMI
managed solely in primary care.
Conclusions
The comparatively high level of suicidal ideation reported,
and the significant levels of self-harm recorded, indicates that
women with SMI in pregnancy are a high-risk population who
require close monitoring in pregnancy.
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